Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Comparison of school protocols under the high incidence conditions due to the Omicron variant

The current study discusses the proactive vs. reactive school protocols relative to the peak demands for resources, break in infection, and the number of days of school lost.

8 Feb 2022

The impact of SARS-CoV-2 variants on clinical trajectory and outcome

The current study describes the results of examining a patient database to understand just how Omicron affected the clinical outcome.

8 Feb 2022

Study suggests hospitalized COVID-19 patients are at higher risk of neurocognitive decline

In a new study, scientists have evaluated patient-reported and clinically tested neuropsychological problems in both ambulatory (outpatients) and hospitalized COVID-19 patients during the early recovery phase.

8 Feb 2022

PCR data sheds light on the dynamics of interspecies pathogen-pathogen interactions

The new study uses PCR data on 17 different pathogens, collected from clinical samples as part of the Seattle Flu Study, a community-based surveillance study of respiratory viral infections.

8 Feb 2022

Reanalysis of the efficacy of COVID-19 vaccines

In a new study, researchers investigated the impact of trial study design and other parameters on the estimates of COVID-19 vaccine efficacy.

8 Feb 2022

SARS-CoV-2 in the exhaled breath of COVID-19 patients might be mainly transmitted via respiratory droplets

Researchers found evidence that SARS-CoV-2 particles are released directly into the air through the breathing of COVID-19 patients resulting in respiratory transmission of the virus.

8 Feb 2022

Missouri’s war on public health shows extent of national rift

Republican Missouri state Sen. Mike Moon believes that covid-19 vaccinations, especially among children, should cease until the long-term effects are known.

8 Feb 2022

Evidence from a major US metropolitan area on home testing and risk factors for acquisition of SARS-CoV-2 infection

A new study analyzed the risk factors for acquiring COVID-19 in a large, prospective cohort of adult residents in the Boston metropolitan area.

8 Feb 2022

Impact of SARS-CoV-2 infection in pregnant women on maternal and perinatal outcomes

Researchers conducted a retrospective cohort analysis by reviewing medical records of pregnant women to examine the impact of SARS-CoV-2 maternal infection on maternal and perinatal outcomes.

8 Feb 2022

Study identifies lower viral load in the nasopharyngeal samples of patients infected with SARS-CoV-2 Omicron variant

In a new study, researchers determined if the higher transmission rate of the SARS-CoV-2 Omicron variant is due to a higher viral load compared to the Delta variant.

8 Feb 2022

Efficacy of MVA-CoV2-S vaccination to prevent SARS-CoV-2 cerebral infection and associated damage

Researchers demonstrated that an MVA vector expressing the SARS-CoV-2 spike protein was 100% effective in preventing neuroinvasion and brain damage by SARS-CoV-2 in transgenic mice.

8 Feb 2022

Characterization of the severity of Omicron relative to Delta in England

Researchers assessed the relative risks of hospitalization and death by SARS-CoV-2 Omicron variant compared to those by Delta (B.1.617.2).

8 Feb 2022

Transmission dynamics of Omicron SARS-CoV-2 variant in England during January 2022

Researchers utilized data from the recent rounds of the REACT-1 study to document the transmission dynamics of SARS-CoV-2, mainly focusing on the Omicron variant in England during January 2022.

8 Feb 2022

Thermo Fisher Scientific launches rapid environmental PCR testing solution that detects in-air SARS-CoV-2 pathogens

Thermo Fisher Scientific Inc. today announced the launch of a new rapid environmental test to help in the fight against COVID-19. The Thermo Scientific Renvo Rapid PCR Test is the latest solution in the company’s in-air pathogen surveillance product portfolio. The Renvo Rapid PCR Test is performed on air samples collected using the company’s Thermo Scientific AerosolSense Sampler.

From Thermo Scientific™ AerosolSense™ Sampler 8 Feb 2022

SARS-CoV-2 cytokine storm inhibited by curcumin nanoparticles

In a recent study published in the journal ACS Applied Bio Materials, researchers demonstrated the inhibitory potential of curcumin-encapsulated polysaccharide nanoparticles (CUR−PS-NPs) against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (CoV2-SP)-stimulated cytokine storm in lung and liver epithelial cells.

8 Feb 2022

Memory B cells induced by mRNA vaccine may help generate antibodies against Omicron

In a recent research article published in the journal of Science Immunology, a team of researchers from Japan performed longitudinal analysis on the cellular composition of receptor-binding domain (RBD) memory B cell subsets and its antibody binding and neutralizing activity against the Beta, Delta, and Omicron variants following the second dose of a messenger ribonucleic acid (mRNA) vaccine.

8 Feb 2022

Assessing the association of COVID-19 and Immunoglobulin A vasculitis in children

In a recent study posted to the Research Square* preprint server, researchers conducted a systematic review to investigate any association between immunoglobulin A (IgA) vasculitis and coronavirus disease 2019 (COVID-19) in children.

8 Feb 2022

Study uncovers a series of natural products that can inhibit the main protease of SARS-CoV-2

The fight against the COVID-19 pandemic is an international scientific challenge regarding the search for strategies to fight the viral infection and prevent its damaging consequences.

7 Feb 2022

Investigating taraxerol as a protease inhibitor against SARS-CoV-2

In a recent study posted to the Research Square preprint* server, a team of researchers investigated the toxicity and absorption, distribution, metabolism, and excretion (ADME) characteristics of a potent herbal drug, taraxerol, in the management of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The paper is under consideration for publication in the Structural Chemistry journal.

7 Feb 2022

SARS-CoV-2 infection-induced antibodies may last more than 20 months

A recent research letter published in the JAMA demonstrated the prevalence and the longevity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in coronavirus disease 2019 (COVID-19) unvaccinated United States (US) adults recovered from the disease in the long term.

7 Feb 2022

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Comparison of school protocols under the high incidence conditions due to the Omicron variant

The impact of SARS-CoV-2 variants on clinical trajectory and outcome

Study suggests hospitalized COVID-19 patients are at higher risk of neurocognitive decline

PCR data sheds light on the dynamics of interspecies pathogen-pathogen interactions

Reanalysis of the efficacy of COVID-19 vaccines

SARS-CoV-2 in the exhaled breath of COVID-19 patients might be mainly transmitted via respiratory droplets

Missouri’s war on public health shows extent of national rift

Evidence from a major US metropolitan area on home testing and risk factors for acquisition of SARS-CoV-2 infection

Impact of SARS-CoV-2 infection in pregnant women on maternal and perinatal outcomes

Study identifies lower viral load in the nasopharyngeal samples of patients infected with SARS-CoV-2 Omicron variant

Efficacy of MVA-CoV2-S vaccination to prevent SARS-CoV-2 cerebral infection and associated damage

Characterization of the severity of Omicron relative to Delta in England

Transmission dynamics of Omicron SARS-CoV-2 variant in England during January 2022

Thermo Fisher Scientific launches rapid environmental PCR testing solution that detects in-air SARS-CoV-2 pathogens

SARS-CoV-2 cytokine storm inhibited by curcumin nanoparticles

Memory B cells induced by mRNA vaccine may help generate antibodies against Omicron

Assessing the association of COVID-19 and Immunoglobulin A vasculitis in children

Study uncovers a series of natural products that can inhibit the main protease of SARS-CoV-2

Investigating taraxerol as a protease inhibitor against SARS-CoV-2

SARS-CoV-2 infection-induced antibodies may last more than 20 months

Industry Focus eBook - Infectious Diseases (1st Edition) eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Industry Focus eBook - Infectious Diseases (1st Edition) eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in